Patents by Inventor Sandra Teixeira

Sandra Teixeira has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS FOR TREATING MEIBOMIAN GLAND DYSFUNCTION WITH LIVER X RECEPTOR AGONISTS
    Publication number: 20220257596
    Abstract: The present invention provides methods for treating meibomian gland dysfunction using liver X receptor (LXR) agonists.
    Type: Application
    Filed: July 13, 2020
    Publication date: August 18, 2022
    Inventors: Christopher M. ADAMS, Qian HUANG, Sandra TEIXEIRA, Brett THIBODEAUX
  • Use of phthalide derivatives for the treatment and prevention of diabetes mellitus
    Publication number: 20070082947
    Abstract: The present invention relates to the use of a compound as effective agent for the prevention or treatment of diabetes mellitus in a mammal. Said compounds being selected from the group of phthalide derivatives and exhibit excellent blood glucose lowering effects and thus are effective agents in the prevention or treatment of diabetes mellitus in mammals.
    Type: Application
    Filed: May 5, 2004
    Publication date: April 12, 2007
    Inventors: Daniel D'Orazio, Antoine De Saizieu, Goede Schueler, Daniel Raederstorff, Sandra Teixeira, Ying Wang Schmidt, Peter Weber, Swen Wolfram
  • Compositions for the treatment and prevention of diabetes mellitus
    Publication number: 20070042057
    Abstract: Compositions comprising a catechin as found in green tea, e.g., epigallocatechin gallate, and ligand which activates the peroxisome proliferatoractivated receptor gamma (PPAR-gamma are useful for the treatment and prevention of diabetes mellitus).
    Type: Application
    Filed: September 15, 2004
    Publication date: February 22, 2007
    Applicant: DSM IP Assets B.V.
    Inventors: Daniel Raederstorff, Sandra Teixeira, Ying Schmidt, Peter Weber, Swen Wolfram
  • Novel nutraceutical compositions comprising epigallocatechin gallate
    Publication number: 20060165671
    Abstract: The invention relates to nutraceutical compositions comprising at least two ingredients from the groups of EGCG, pantethine or a metabolite thereof, phytanic acid, lipoic acid, policosanol and coenzyme Q-10 and their use in the treatment or prevention of diabetes or obesity.
    Type: Application
    Filed: September 30, 2003
    Publication date: July 27, 2006
    Inventors: Daniel Raederstorff, Sandra Teixeira, Peter Weber
  • Novel nutraceutical compositions comprising boitin
    Publication number: 20050256178
    Abstract: Nutraceutical compositions comprise biotin in an amount sufficient to administer to a subject a daily dosage of 0.01 mg per kg body weight to about 3 mg per kg body weight and at least one additional component selected from pantethine or a metabolite thereof, EGCG, phytanic acid, lipoic acid and policosanol. The compositions are useful for the treatment of both type 1 and 2 diabetes, and for the prevention of type 2 diabetes in those individuals with pre-diabetes, or impaired glucose tolerance (IGT) or obesity.
    Type: Application
    Filed: August 18, 2003
    Publication date: November 17, 2005
    Inventors: Manfred Eggersdorfer, Daniel Raederstorff, Sandra Teixeira, Peter Weber